Ofloxacino Altan (Ofloxacin)

Ofloxacino Altan is a broad‑spectrum antibacterial that targets common bacterial pathogens in several organ systems.

• Urinary tract infection: helps eradicate the causative bacteria and relieve symptoms.
• Respiratory tract infection: aids in clearing bacterial pneumonia and bronchitis.
• Skin and soft‑tissue infection: assists in eliminating staphylococcal and streptococcal organisms.
• Gonorrhoea: provides effective bacterial eradication in uncomplicated cases.
• Prostatitis chronic bacterial: contributes to bacterial clearance in chronic prostatitis.
• Eye infections (topical formulation): treats bacterial conjunctivitis and keratitis.

• Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription and repair. By blocking these enzymes, the drug prevents bacterial cell division and leads to bacterial cell death, providing a bactericidal effect against susceptible Gram‑negative and Gram‑positive organisms.

Adverse reactions to Ofloxacino Altan vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: watery stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Dizziness: occasional light‑headedness.
• Rash: mild skin erythema or itching.
• Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects

• Tendon rupture: sudden pain or loss of function, especially in the Achilles.
• Peripheral neuropathy: tingling, numbness or weakness in extremities.
• QT interval prolongation: cardiac rhythm disturbances detectable on ECG.
• Severe hypersensitivity: anaphylaxis, angio‑edema or Stevens‑Johnson syndrome.
• Hepatotoxicity: elevated liver enzymes or jaundice.
• Clostridioides difficile infection: severe colitis following dysbiosis.

When prescribing Ofloxacino Altan, clinicians should consider several safety aspects.

• Renal impairment: adjust dose in patients with reduced kidney function.
• Hepatic impairment: use with caution in liver disease.
• Pregnancy: avoid use unless clearly needed, as animal studies show risk.
• Age >65 years: monitor for tendon and CNS effects.
• Concomitant QT‑prolonging drugs: assess cardiac risk.
• Store below 25°C: keep in the original container, protect from moisture and light.

Ofloxacino Altan may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminium or magnesium: reduce absorption of ofloxacin.
• Warfarin: may increase INR values and bleeding risk.
• Theophylline: elevated plasma levels can cause toxicity.
• Cyclosporine: increased risk of nephrotoxicity.
• NSAIDs (non‑selective): higher chance of CNS stimulation.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduction in contraceptive effectiveness.\n- Diabetic agents: may affect blood glucose control.
• Corticosteroids: increased risk of tendon injury.
• Antidepressants (SSRIs): potential for QT prolongation.
• Iron supplements: may diminish ofloxacin absorption.